Founded by Bernie Schaeffer, we provide stock news, options insights, and premium trading services to options traders

 

BACKED BY 170+ YEARS OF MARKET EXPERTISE

Get Schaeffer’s market outlook every Monday, straight to your inbox.

 

 
 
 
 
 
 
 
 
X
Advanced Micro Devices stock, AMD stock, AMD stock news
Semiconductor standout Advanced Micro Devices Inc (NASDAQ:AMD) is up 4% to trade at $173.04 today, after UBS hiked its price target to $210 from $150. With the stock trading at its highest in nearly a ... Semiconductor standout Advanced Micro Devices Inc (NASDAQ:AMD) is up 4% to trade at $173.04 today, after UBS hiked its price target to $210 from $150. With the stock trading at its highest in nearly a year and the chipmaker's second-quarter earnings report due out after the close on Aug. 5, options ... Keep Reading
Schaeffer’s Midday Market Check Daily Newsletter
Stocks are struggling for direction today, despite the trade deal between the EU and U.S. announced over the weekend. The Dow Jones Industrial Average (DJI) and S&P 500 Index (SPX) are sitting on ... Stocks are struggling for direction today, despite the trade deal between the EU and U.S. announced over the weekend. The Dow Jones Industrial Average (DJI) and S&P 500 Index (SPX) are sitting on either side of breakeven, while the Nasdaq Composite (IXIC) trades quietly higher as investors are ... Keep Reading
Cisco stock, CSCO stock, Cisco Systems stock
Evercore ISI downgraded Cisco Systems Inc (NASDAQ:CSCO) stock to "in line" from "outperform," with the analyst in coverage noting that any potential upside is already priced in. The firm also addresse ... Evercore ISI downgraded Cisco Systems Inc (NASDAQ:CSCO) stock to "in line" from "outperform," with the analyst in coverage noting that any potential upside is already priced in. The firm also addressed the lack of disclosed artificial intelligence (AI) revenue numbers. At last glance, CSCO was down ... Keep Reading
Arrow pointing up, Stock price increasing, Bullish stock price movement
Biotech stock Celcuity Inc (NASDAQ:CELC) is skyrocketing today, up 221% at $43.76 at last glance, after upbeat phase 3 trial results for its advanced breast cancer therapy, gedatolisib, which it hopes ... Biotech stock Celcuity Inc (NASDAQ:CELC) is skyrocketing today, up 221% at $43.76 at last glance, after upbeat phase 3 trial results for its advanced breast cancer therapy, gedatolisib, which it hopes will have Food & Drug Administration (FDA) approval by the end of the year. The treatment demo ... Keep Reading